Dr. Steven Alexander Latosinsky, MD

Dr. Latosinsky practices at Corewell Health Zeeland Hospital in Zeeland, Michigan, part of Corewell Health.

Dr. Latosinsky's NPI, 1457839052, was assigned on August 6, 2018. Dr. Latosinsky holds Michigan license 4301504588.

Dr. Latosinsky's primary practice is Corewell Health Zeeland Hospital, at 8333 Felch St, Zeeland, MI 49464 in Ottawa County. The practice phone is (616) 772-4644.

Dr. Latosinsky's primary practice is Corewell Health Zeeland Hospital in Zeeland, Michigan, part of Corewell Health. Dr. Latosinsky is also affiliated with Corewell Health Grand Rapids Hospitals - Butterworth. The medical group on file is Emergency Care Specialists (ECS). Dmand AI also links Dr. Latosinsky to 4 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Latosinsky practices, 6 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Latosinsky's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Latosinsky is licensed in Michigan.

CMS data shows 212 Medicare services from Dr. Latosinsky across 4 procedure codes in 2024, for 206 Medicare patients. Medicare paid $25,146 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 206 Medicare patients who saw Dr. Latosinsky in 2024. The largest group is 75 to 84, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Latosinsky's median patient age at 42, with 56% women.

In 2024, Dr. Latosinsky wrote 308 Medicare Part D claims for 205 patients. 93% of them were for generic drugs. CMS names the drug for 172 of them, across 7 drugs with 11 or more claims each, at $1,305 in total drug cost. In 2023, CMS named 219 claims across 7 drugs.

Dr. Latosinsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Latosinsky, published from 2015 to 2020. 2019 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Canada and Delphi Technique. Dr. Latosinsky has published most often in Breast J. Dr. Latosinsky's most frequent co-authors are Kimberly Anne Bertens, MD, Roberto Hernandez-Alejandro, MD and Alexandra C. Istl.

Dmand AI links Dr. Latosinsky to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 1 general payment to Dr. Latosinsky from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $15.